Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Accenture
QuintilesIMS
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission
Teva
Citi
Julphar

Generated: February 19, 2018

DrugPatentWatch Database Preview

DUREZOL Drug Profile

« Back to Dashboard

When do Durezol patents expire, and when can generic versions of Durezol launch?

Durezol is a drug marketed by Novartis Pharms Corp and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has six patent family members in five countries.

The generic ingredient in DUREZOL is difluprednate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the difluprednate profile page.
Summary for DUREZOL
International Patents:6
US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Bulk Api Vendors: 32
Clinical Trials: 5
Patent Applications: 4,091
Drug Prices:see details
DailyMed Link:DUREZOL at DailyMed
Drug patent expirations by year for DUREZOL

US Patents and Regulatory Information for DUREZOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp DUREZOL difluprednate EMULSION;OPHTHALMIC 022212-001 Jun 23, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Novartis Pharms Corp DUREZOL difluprednate EMULSION;OPHTHALMIC 022212-001 Jun 23, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp DUREZOL difluprednate EMULSION;OPHTHALMIC 022212-001 Jun 23, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for DUREZOL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Ophthalmic Emulsion 0.05% ➤ Subscribe 5/1/2014

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Covington
Fuji
Teva
Johnson and Johnson
Cantor Fitzgerald
US Army
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot